Estimating the number of new hepatitis C infections in Australia in 2015, prior to the scale‐up of direct‐acting antiviral treatment-Reference-Cited by-同舟云学术

Estimating the number of new hepatitis C infections in Australia in 2015, prior to the scale‐up of direct‐acting antiviral treatment

Published:2021-03-20 Issue:8 Volume:36 Page:2270-2274
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Palmer Anna Y¹^ORCID,Wilkinson Anna¹²,Aitken Campbell¹,Dietze Paul¹²³,Dore Gregory J⁴,Maher Lisa⁴,Sacks‐Davis Rachel¹²,Stoove Mark¹²,Wilson David¹,Hellard Margaret¹²⁵⁶⁷,Scott Nick¹²

Affiliation:

1. Disease Elimination Program Burnet Institute Melbourne Victoria Australia

2. Department of Epidemiology and Preventive Medicine Monash University Melbourne Victoria Australia

3. National Drug Research Institute Curtin University Perth Western Australia Australia

4. Kirby Institute University of New South Wales Sydney New South Wales Australia

5. Department of Infectious Diseases The Alfred and Monash University Melbourne Victoria Australia

6. Peter Doherty Institute for Infection and Immunity Parkville Victoria Australia

7. School of Population and Global Health University of Melbourne Parkville Victoria Australia

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.15485

Reference25 articles.

1. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission

2. WHO.Global health sector strategy on viral hepatitis 2016–2021. Global Hepatitis Programme Department of HIV/AIDS.2016;(June):56. Available from:https://www.who.int/hepatitis/strategy2016‐2021/ghss‐hep/en/

3. The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: Impact of direct acting antivirals

4. Kirby Institute.HIV viral hepatitis and sexually transmissible infections in Australia: annual surveillance report 2018. Sydney: Kirby Institute UNSW Sydney;2018. Available from:https://kirby.unsw.edu.au/report/hiv-viral‐hepatitis‐and‐sexually‐transmissible‐infections‐australia‐annual‐surveillance

5. National update on HIV viral hepatitis and sexually transmissible infections in Australia: 2009–2018. Sydney: Kirby Institute UNSW Sydney. Available from:https://kirby.unsw.edu.au/report/national-update-hiv-viral‐hepatitis‐and‐sexually‐transmissible‐infections‐australia‐2009‐2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence of primary hepatitis C virus infection among people who inject drugs in Australia pre‐ and post‐unrestricted availability of direct acting antiviral therapies;Addiction;2022-12-29

2. Hepatitis C incidence among patients attending primary care health services that specialise in the care of people who inject drugs, Victoria, Australia, 2009 to 2020;International Journal of Drug Policy;2022-05

3. Assessment of the cost-effectiveness of Australia's risk-sharing agreement for direct-acting antiviral treatments for hepatitis C: a modelling study;The Lancet Regional Health - Western Pacific;2022-01

4. Estimating the number of new hepatitis C infections in Australia in 2015, prior to the scale‐up of direct‐acting antiviral treatment;Journal of Gastroenterology and Hepatology;2021-03-20